Used primarily in pharmaceutical research as a potent and selective serotonin 5-HT1A receptor agonist. It exhibits anxiolytic and antidepressant-like effects in preclinical models, making it a candidate for the development of treatments for anxiety disorders and depression. It also shows neuroprotective properties and has been studied for potential use in neurodegenerative conditions. Due to its high affinity for 5-HT1A receptors, it is employed as a radioligand in receptor binding assays and neuroimaging studies to map serotonin receptor distribution in the brain. Its ability to cross the blood-brain barrier enhances its utility in central nervous system drug development.